Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: January 24, 2014
Reporting Period: Fourth quarter and full year ended December 31, 2013
This filing serves as a notification that the Company issued a press release announcing its financial results for the fourth quarter and twelve months of 2013. The detailed financial data is contained in the press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) incorporated by reference.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced press release and supplemental exhibits, which are not included in the provided text.
Material Changes
Comparison to Prior Period: The filing text does not disclose specific material changes or year-over-year comparisons. It only confirms that results for the fourth quarter and full year 2013 were announced.
Guidance, Outlook, and Risks
Management Commentary and Outlook: No specific guidance, outlook, or management commentary is detailed in the body of this Form 8-K. Such information is expected to be found in the referenced press release (Exhibit 99.1).
Risks and Contingencies: No specific risks or contingencies are listed in this filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 24, 2014) for specific Q4 and full-year 2013 financial results.
- Access Exhibit 99.2 (Supplemental information on www.bms.com) for additional data not included in the press release.
- Verify the Company's forward-looking statements and guidance provided in the press release.
- Confirm the impact of any unusual items or one-time charges mentioned in the detailed financial statements.